Windward Bio Group IPO of 10.3M Shares Prices at $17 Each

Résumé détaillé

Windward Bio Group said its initial public offering of 10.3 million shares priced at $17 each. The Basel, Switzerland, company had expected to sell 10.3 million shares at a price…

Windward Bio Group said its initial public offering of 10.3 million shares priced at $17 each.

The Basel, Switzerland, company had expected to sell 10.3 million shares at a price between $16 and $18 each. Its largest stockholders include Novo Holdings and OrbiMed.

Windward also sold stock and warrants to Sanofi in a $50 million private placement concurrently with the IPO.

In September, Windward reported positive interim results from the Phase 2 portion of a clinical trial evaluating twice-yearly dosing of WIN378 in asthma.

The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.

Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.

Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.

Début de l'article, extrait de Morningstar. Pour lire la suite, ouvrez l'article chez le média.